UniProt ID | WIPI2_MOUSE | |
---|---|---|
UniProt AC | Q80W47 | |
Protein Name | WD repeat domain phosphoinositide-interacting protein 2 | |
Gene Name | Wipi2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 445 | |
Subcellular Localization |
Preautophagosomal structure membrane Peripheral membrane protein Cytoplasmic side . Enriched at preautophagosomal structure membranes in response to PtdIns3P. Dissociates from mature phagosome membranes. |
|
Protein Description | Early component of the autophagy machinery being involved in formation of preautophagosomal structures and their maturation into mature phagosomes in response to phosphatidylinositol 3-phosphate (PtdIns3P). Recruits the ATG12-ATG5-ATG16L1 complex to omegasomes, resulting in ATG8 family proteins lipidation and starvation-induced autophagy. Omegasomes are derived from ER and serve as intermediates for genesis of isolation membrane (also called preautophagosome) from ER cisternae membranes.. | |
Protein Sequence | MNLASQSGEAGAGQLLFANFNQDNTSLAVGSKSGYKFFSLSSVDKLEQIYECTDTEDVCIVERLFSSSLVAIVSLKAPRKLKVCHFKKGTEICNYSYSNTILAVKLNRQRLIVCLEESLYIHNIRDMKVLHTIRETPPNPAGLCALSINNDNCYLAYPGSASIGEVQVFDTINLRAANMIPAHDSPLAALAFDASGTKLATASEKGTVIRVFSIPEGQKLFEFRRGVKRCVSICSLAFSMDGMFLSASSNTETVHIFKLEAVREKPPEEPTTWTGYFGKVLMASTSYLPSQVTEMFNQGRAFATVRLPFCGHKNICSLTTIQKIPRLLVGASDGYLYMYNLDPQEGGECALMRQHRLDGSMETTSEIVDSASHDCPLATQTYGTAAAKGAYVPSSPTRLGKGQDANLEAYTDDLGAVGGACLEDEASALRLDEDSEHPPMILRTD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
79 | Ubiquitination | IVSLKAPRKLKVCHF EEECCCCCCEEEEEC | 62.89 | 27667366 | |
198 | Ubiquitination | AFDASGTKLATASEK EECCCCCEEEEECCC | 39.38 | 22790023 | |
203 | Phosphorylation | GTKLATASEKGTVIR CCEEEEECCCCCEEE | 35.17 | 21454597 | |
205 | Malonylation | KLATASEKGTVIRVF EEEEECCCCCEEEEE | 58.34 | 26320211 | |
205 | Ubiquitination | KLATASEKGTVIRVF EEEEECCCCCEEEEE | 58.34 | 27667366 | |
207 | Phosphorylation | ATASEKGTVIRVFSI EEECCCCCEEEEEEC | 24.67 | 21454597 | |
276 | Phosphorylation | EPTTWTGYFGKVLMA CCCCCCCCCCCHHHH | 11.20 | 29514104 | |
323 | Acetylation | CSLTTIQKIPRLLVG CCCHHHCCCCEEEEC | 51.32 | 22826441 | |
323 | Ubiquitination | CSLTTIQKIPRLLVG CCCHHHCCCCEEEEC | 51.32 | 22790023 | |
360 | Phosphorylation | RQHRLDGSMETTSEI EEEECCCCCEEHHHH | 17.08 | 26239621 | |
363 | Phosphorylation | RLDGSMETTSEIVDS ECCCCCEEHHHHHHH | 27.29 | 26239621 | |
364 | Phosphorylation | LDGSMETTSEIVDSA CCCCCEEHHHHHHHH | 15.85 | 26239621 | |
365 | Phosphorylation | DGSMETTSEIVDSAS CCCCEEHHHHHHHHC | 32.52 | 26239621 | |
370 | Phosphorylation | TTSEIVDSASHDCPL EHHHHHHHHCCCCCC | 22.30 | 26239621 | |
372 | Phosphorylation | SEIVDSASHDCPLAT HHHHHHHCCCCCCCC | 24.66 | 26239621 | |
379 | Phosphorylation | SHDCPLATQTYGTAA CCCCCCCCEECCCCC | 29.18 | 25159016 | |
381 | Phosphorylation | DCPLATQTYGTAAAK CCCCCCEECCCCCCC | 21.40 | 25159016 | |
382 | Phosphorylation | CPLATQTYGTAAAKG CCCCCEECCCCCCCC | 11.58 | 25159016 | |
384 | Phosphorylation | LATQTYGTAAAKGAY CCCEECCCCCCCCCC | 11.60 | 24224561 | |
391 | Phosphorylation | TAAAKGAYVPSSPTR CCCCCCCCCCCCCCC | 22.89 | 28833060 | |
394 | Phosphorylation | AKGAYVPSSPTRLGK CCCCCCCCCCCCCCC | 38.62 | 24925903 | |
395 | Phosphorylation | KGAYVPSSPTRLGKG CCCCCCCCCCCCCCC | 24.99 | 24925903 | |
397 | Phosphorylation | AYVPSSPTRLGKGQD CCCCCCCCCCCCCCC | 40.24 | 24925903 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WIPI2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WIPI2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DSG1_HUMAN | DSG1 | physical | 26496610 | |
T2FA_HUMAN | GTF2F1 | physical | 26496610 | |
MYO10_HUMAN | MYO10 | physical | 26496610 | |
UPAR_HUMAN | PLAUR | physical | 26496610 | |
VA0D1_HUMAN | ATP6V0D1 | physical | 26496610 | |
PACS2_HUMAN | PACS2 | physical | 26496610 | |
MACF1_HUMAN | MACF1 | physical | 26496610 | |
BCAS3_HUMAN | BCAS3 | physical | 26496610 | |
CHD9_HUMAN | CHD9 | physical | 26496610 | |
DI3L2_HUMAN | DIS3L2 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...